Montis Capital invested over PLN 7M in Biotts, a Wroclaw biotech company developing drug-delivery technology.
Biotts is a biotech company specializing in Transdermal Drug Delivery, utilizing its proprietary Multifunctional Transdermal Carrier Y (MTC-Y™) technology to enhance drug delivery through the skin
Biotts is a biotech company specializing in Transdermal Drug Delivery, utilizing its proprietary Multifunctional Transdermal Carrier Y (MTC-Y™) technology to enhance drug delivery through the skin.